Synaptic Proteins May Be Starting Point for Dementia Treatment
One of the most intriguing properties of the brain is its means to undergo synaptic plasticity which represents the basis for learning and memory, abilities that severely decline in the case of a dementia. New research, published on 9 January in the scientific journal Brain, suggests that particular proteins important in the communication between neurons could be targets for early interventions in patients with different types of dementias.
In the nervous system, a synapse is the place where signals are passed from neuron to neuron. The recently published paper focuses on synaptic dysfunction and its impact on dementia severity and cognition in the elderly with various dementia diagnoses. In addition to Alzheimer´s disease, the Lewy body dementias are the most common forms of neurodegenerative dementias with a very severe prognosis.
“Our findings suggest that particular pre- and postsynaptic proteins have an important predictive and discriminative molecular fingerprint in neurodegenerative diseases and represent potential targets for early disease intervention, such as synaptic regeneration,” Erika Bereczki says, first author of the publication and researcher at the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet.
A new and broad perspective across dementias
Synaptic loss, a prominent feature in Alzheimer's disease is strongly correlated with dementia severity. Much less is known regarding synaptic loss in Lewy body dementias.
The study is the first in-depth quantitative proteome study on pre-frontal post-mortem brain tissues where beside the whole proteome comparison, the researchers also profiled the entire synaptic proteome of Alzheimer's disease, Parkinson's disease with dementia and dementia with Lewy bodies patients and compared them to control cases. Taking benefit of the technological advance of proteomics analyses (a technique for large-scale studies of proteins) Erika Bereczki and her colleagues have identified key synaptic proteins underlying synaptic dysfunction which were associated with the degree of cognitive decline across dementias.
Interesting targets for early interventions
“Our results suggest shared mechanisms, with major implications for prognostic and diagnostic marker development as well as advancing future therapeutic interventions for improving the disease course. This places synaptic dysfunction and repair approaches in the spotlight of attention, especially since the therapeutic intervention window for synaptic repair and regeneration is longer than the recent toxin-clearance approaches”, Erika Bereczki says.
The study involved collaborators from Sweden, Norway, Hungary and the UK and was supported by grants from Alzheimerfonden, Parkinsonfonden, Demensfonden, Karolinska Institutet geriatric funds and UK Brains for Dementia Research among others.
This article has been republished from materials provided by the Karolinska Institute. Note: material may have been edited for length and content. For further information, please contact the cited source.
Reference: Bereczki, E., Branca, R. M., Francis, P. T., Pereira, J. B., Baek, J. H., Hortobágyi, T., ... & Aarsland, D. (2017). Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach. Brain.
Rapid Removal of Arsenic From Drinking Water...By Moss!News
A moss capable of removing arsenic from contaminated water has been discovered by researchers. And it happens quickly – in just one hour, the arsenic level is so low that the water is no longer harmful for people to drink.READ MORE
Stable Beta-Amyloid Dimers Identified in Alzheimer’s BrainsNews
A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.